文献速递癫痫神经重症与神经感染

院前咪达唑仑使用与院外癫痫持续状态患者结局

Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus.
PubMed 文献 · Neurology · 2020-09-17

这项横断面分析纳入2013至2018年由紧急医疗服务机构治疗的2494例成人癫痫持续状态患者,评估苯二氮䓬类药物使用及低剂量与突破性发作和呼吸支持的关系。结果显示62%患者接受咪达唑仑,但无人剂量和途径符合国家指南;较高剂量与较低救援治疗 odds 相关且不增加呼吸支持。

要点

  • 多数癫痫持续状态患者未接受循证苯二氮䓬治疗
  • 较高咪达唑仑剂量与较低救援治疗需求相关
  • 较高剂量未增加呼吸支持需求

核心结论

  • 绝大多数癫痫持续状态患者未接受循证苯二氮䓬治疗,较高咪达唑仑剂量减少救援治疗且无呼吸 harm 证据。

研究设计与样本

  • 横断面分析纳入2013至2018年由紧急医疗服务机构治疗的2494例成人癫痫持续状态患者,咪达唑仑是唯一使用的苯二氮䓬。

主要发现

  • 2494例患者平均年龄54.0岁,1146例(46%)为女性;1537例接受任意剂量咪达唑仑,给药率62%。
  • 282例(18%)需要第二次咪达唑仑剂量救援治疗。
  • 较高咪达唑仑剂量与较低救援治疗 odds 相关(OR 0.8;95%CI 0.7-0.9)。
  • 较高咪达唑仑剂量与呼吸支持增加无关,调整后与呼吸支持需求减少相关(OR 0.9;95%CI 0.8-1.0)。

临床怎么用

  • 院前癫痫持续状态应给予循证剂量的苯二氮䓬,不应因担心呼吸抑制而 withheld。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the use of benzodiazepines and the association between low benzodiazepine dose, breakthrough seizures, and respiratory support in patients with status epilepticus. METHODS: In this cross-sectional analysis of adult patients with status epilepticus treated by an emergency medical services agency from 2013 to 2018, the primary outcome was treatment with a second benzodiazepine dose, an indicator for breakthrough seizure. The secondary outcome was receiving respiratory support. Midazolam was the only benzodiazepine administered. RESULTS: Among 2,494 patients with status epilepticus, mean age was 54.0 years and 1,146 (46%) were female. There were 1,537 patients given midazolam at any dose, yielding an administration rate of 62%. No patients received a dose and route consistent with national guidelines. Rescue therapy with a second midazolam dose was required in 282 (18%) patients. Higher midazolam doses were associated with lower odds of rescue therapy (odds ratio [OR], 0.8; 95% confidence interval [CI], 0.7-0.9) and were not associated with increased respiratory support. If anything, higher doses of midazolam were associated with decreased need for respiratory support after adjustment (OR, 0.9; 95% CI, 0.8-1.0). CONCLUSIONS: An overwhelming majority of patients with status epilepticus did not receive evidence-based benzodiazepine treatment. Higher midazolam doses were associated with reduced use of rescue therapy and there was no evidence of respiratory harm, suggesting that benzodiazepines are withheld without clinical benefit. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with status epilepticus, higher doses of midazolam led to a reduced use of rescue therapy without an increased need for ventilatory support.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Guterman EL, Sanford JK, Betjemann JP, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology. 2020. PMID: 32943481. doi:10.1212/WNL.0000000000010913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。